Interview Series 20th March 2026
From the helm: Clarity Pharma (ASX:CU6), Chair, Alan Taylor & Senior Bell Potter Analyst John Hester
In this episode of From the Helm, Grady is joined by Clarity Pharmaceuticals (ASX:CU6) Executive Chairperson Alan Taylor & Bell Potter Senior Analyst John Hester, for a deep dive into their next-generation radiopharmaceutical technology for both early-stage cancer diagnosis and treatment.
-
_600_338.png)
Interview Series 20 Mar 2026
From the helm: Summerset Group Holdings (ASX:SNZ), CFO, Margaret Warrington.
-
_600_338.png)
Interview Series 20 Mar 2026
From the helm: Amplia (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.
-
_600_338.png)
Interview Series 20 Mar 2026
From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.
-
_600_338.png)
Interview Series 20 Mar 2026
From the helm: Neuren Pharmaceuticals (ASX:NEU), CEO, Jon Pilcher.
-
_600_338.png)
Interview Series 20 Mar 2026
From the helm: Saluda Medical (ASX:SLD), President & CEO, Barry Regan
-
_600_338.png)
Interview Series 20 Mar 2026
From the helm: Mesoblast (ASX:MSB), Director, Silviu Itescu
-
_600_338.png)
Interview Series 20 Mar 2026
From the helm: 4DMedical (ASX:4DX), Founder & CEO, Andreas Fouras.
-
_600_338.png)
Interview Series 20 Mar 2026
From the helm: EBR Systems (ASX:EBR), President & CEO, John McCutcheon
-
_(1)_600_338.png)
Market wraps 20 Mar 2026
Weekly Wrap 20 March
-
_(1)_600_338.png)
Market wraps 13 Mar 2026
Weekly Wrap 13 March
-
_600_338.png)
Market wraps 12 Mar 2026
Morning Bell - Max Lo Certo
-
_600_338.png)
Market wraps 11 Mar 2026
Morning Bell - Max Lo Certo